Back to mobile site

Sangamo Biosciences, Inc. (SGMO) Tops Q2 EPS by 3c

July 24, 2013 5:27 PM EDT
Sangamo Biosciences, Inc. (NASDAQ: SGMO) reported Q2 EPS of ($0.10), $0.03 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $6.93 million versus the consensus estimate of $4.77 million.

For earnings history and earnings-related data on Sangamo Biosciences, Inc. (SGMO) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings